In 2006, then-Senator Barack Obama introduced the Genomics and Personalized Medicine Act to the US Congress. Now, the bill is being reintroduced as GPMA 2010 as a response to growing public awareness of genomic tests, according to Genomics Law Report's Dan Vorhaus and Meggan Bushee. The act aims to expand and accelerate genomic research to improve disease diagnosis and to expand the use of personalized medicine, among other things.